The recent new breakthrough discovery of CD4 T Cells expressing high CD26 was very encouraging.
https://www.sciencedaily.com/releases/2017/12/171220091745.htm
Is the company also conducting specific work on CD4 T Cells as part of their peptide vaccine validation research or is the focus solely on CD8 T Cells? If so, are you able to elaborate as to why?
Thanks,
Tony
The recent new breakthrough discovery of CD4 T Cells expressing...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.005(0.39%) |
Mkt cap ! $746.5M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.28 | $4.538M | 3.587M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25835 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 67637 | 4 |
View Market Depth
| Last trade - 11.26am 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |